NIH sets sights on $323m more for Alzheimer's
This article was originally published in Scrip
If Dr Francis Collins, director of the National Institutes of Health (NIH) had just $323m more in his agency's purse, it could do so much more to advance research into Alzheimer's disease, he said in a special funding request, known as a "bypass budget," which was transmitted directly to President Barack Obama, who will subsequently send it on to Congress, without having to go through the normal White House request channels.
You may also be interested in...
With new funding in hand, Moderna and its infectious disease venture Valera are going full-speed ahead with a Zika vaccine, taking an mRNA approach, which they said could be a more rapid strategy to try to stop the disease.
Allergan CEO Brent Saunders vows not to engage in price gouging and says his firm will limit cost increases to single-digit percentages, occurring only once per year. But it's unclear whether Saunders will stand as a lone wolf in the industry or if others will make similar pledges.
Hillary Clinton's plan to rein in high prices of older medicines, which includes creating a federal panel that has authority to impose fines, may grab headlines, but some analysts think it's unlikely to get very far in a divided Washington.